Journal Article

Economic evaluation of community acquired pneumonia management strategies: A systematic review of literature

Gold, Lisa, Akram, Raisul, Sarker, Abdur Razzaque, Sultana, Marufa, Ali, Nausad

2019

Overview

Community-acquired pneumonia (CAP) is a major cause of mortality and morbidity worldwide. Efficient use of resources is fundamental for best use of money among the available and novel treatment options for the management of pneumonia. The objective of this study was to systematically review the economic analysis of management strategies of pneumonia. A systematic search was performed using Academic Search Complete, MEDLINE, EconLit, Global health, MEDLINE complete and Embase databases using specific subject headings or key words in May 2018 without restricting publication year. All search results were recorded and any type of economic evaluation for management of CAP was included for detailed review. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) checklist was used for quality appraisal. Nineteen studies met the inclusion criteria; ten studies were trial based, five conducted analysis using model based techniques and the rest of the studies were either based on observational, record review or pre-post intervention studies. Most of the studies conducted cost-effectiveness analysis (n = 15) and compared different combinations of antimicrobials. Most were based on developed countries (n = 17), considered adult age groups (n = 16) and used a provider perspective (n = 14). Nine studies reported dominant alternatives (lower cost with higher benefit). Sensitivity analysis was performed by the majority of studies (n = 15). Fourteen studies were assessed as either being excellent, very good or good quality, with no relationship found between publication year and study quality. Methodological variation, type of microbial used, perspective, costs and outcome measures limit the compatibility among the results of the included studies. Economic evaluation of interventions for management of CAP to date supports cost-effectiveness of studied interventions. However, evidence relates largely to antimicrobials choice in older populations in developed countries. Parallel economic evaluation of different management strategies of CAP is recommended for both developed and developing countries to support rigorous and robust comparative economic analysis within health care systems. PROSPERO registration no: CRD42018097174.

• Publisher: Public Library of Science,Public Library of Science (PLoS)
• Subject: Analysis / Anti-Bacterial Agents - economics / Anti-Bacterial Agents - therapeutic use / Anti-infective agents / Antibiotics / Antimicrobial agents / Asthma / Biology and Life Sciences / Care and treatment / Communities / Community-Acquired Infections - drug therapy / Community-Acquired Infections - economics / Cost benefit analysis / Delivery of Health Care / Developed countries / Developing countries / Diabetes / Disease Management / Economic analysis / Economics / Evaluation / Global health / Health economics / Hospitals / Humans / Industrialized countries / Infections / Infectious diseases / LDCs / Literature reviews / Low income groups / Management / Medical care / Medicine and Health Sciences / Microorganisms / Morbidity / Mortality / Novels / Pneumonia / Pneumonia - drug therapy / Pneumonia - economics / Practice guidelines (Medicine) / Public health / Quality-Adjusted Life Years / Research and Analysis Methods / Reviews / Searching / Sensitivity analysis / Social change / Social Sciences / Studies / Subject heading schemes / Systematic review / United States / World health